🇺🇸 FDA

Company profile · Sponsor

Pfizer

E4806AD · EMA pharma PARIS, FR
Pipeline
24
Drugs
0
Patents
0

Quick answer

Pfizer (E4806AD) is a pharma company. headquartered in PARIS, FR. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E4806AD
Exchange EMA
Company type pharma
Headquarters PARIS, FR

Pipeline (24)

Search pipeline →

  1. ATM-AVI

    Pfizer

    Serious Bacterial Infection

    phase 3 other terminated

    1 trial

  2. ATM-AVI

    Pfizer

    Complicated Intra-abdominal Infection

    phase 3 small molecule completed

    1 trial

  3. Amlodipine/atorvastatin single pill

    Pfizer

    Hypertension

    phase 3 small molecule completed

    1 trial

  4. Anidulafungin

    Pfizer

    Candidemia

    phase 3 small molecule completed

    1 trial

  5. Avelumab

    Pfizer

    Advanced Malignancies

    phase 3 small molecule active

    1 trial

  6. Bevacizumab

    Pfizer

    Renal Cell Carcinoma

    phase 3 small molecule completed

    1 trial

  7. Bevacizumab-Pfizer

    Pfizer

    Non-Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  8. Bosutinib

    Pfizer

    Chronic Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  9. Brentuximab vedotin

    Pfizer

    Diffuse Large B-cell Lymphoma

    phase 3 small molecule active

    1 trial

  10. CAZ-AVI

    Pfizer

    Complicated Intra-Abdominal Infection

    phase 3 small molecule completed

    1 trial

  11. CP 751,871 (Figitumumab)

    Pfizer

    Carcinoma, Large Cell

    phase 3 small molecule terminated

    1 trial

  12. CP-690,550

    Pfizer

    Arthritis, Rheumatoid

    phase 3 small molecule completed

    3 trials

  13. Capecitabine

    Pfizer

    Breast Neoplasms

    phase 3 small molecule terminated

    1 trial

  14. Ceftaroline

    Pfizer

    Community-Acquired Bacterial Pneumonia

    phase 3 small molecule completed

    1 trial

  15. Ceftazidime - Avibactam ( CAZ-AVI)

    Pfizer

    Complicated Urinary Tract Infection

    phase 3 small molecule completed

    1 trial

  16. Ceftazidime-avibactam

    Pfizer

    Complicated Intra-abdominal Infection

    phase 3 small molecule completed

    1 trial

  17. Chemotherapy + avelumab followed by avelumab + talazoparib

    Pfizer

    Ovarian Cancer

    phase 3 small molecule terminated

    1 trial

  18. Edotecarin

    Pfizer

    Glioblastoma

    phase 3 small molecule completed

    1 trial

  19. Eplerenone

    Pfizer

    Heart Failure

    phase 3 small molecule completed

    1 trial

  20. Eplerenone

    Pfizer

    Hypertension

    phase 3 small molecule completed

    2 trials

  21. MenACWY-TT

    Pfizer

    Meningococcal ACWY Disease

    phase 3 mab completed

    1 trial

  22. Moxifloxacin

    Pfizer

    Chronic Bronchitis

    phase 3 small molecule completed

    1 trial

  23. PD-0332991

    Pfizer

    Breast Neoplasms

    phase 3 small molecule completed

    1 trial

  24. PF-02341066

    Pfizer

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    2 trials

Frequently asked questions

What is Pfizer?

Pfizer (E4806AD) is a pharma company. headquartered in PARIS, FR. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Pfizer sponsor?

We track 24 ClinicalTrials.gov-linked programs for Pfizer, including ATM-AVI and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Pfizer company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.